Mitsuhiko Osaki

8.4k citations
158 papers · 6.8k indexed · 1 hit paper · h-index 44
Topics
Cancer-related Molecular Pathways (18 papers)RNA Interference and Gene Delivery (16 papers)MicroRNA in disease regulation (12 papers)

In The Last Decade

Mitsuhiko Osaki

154 papers receiving 6.7k citations

Hit Papers

PI3K-Akt pathway: Its functions and alterations in human ...200420262011201820042505007501000

Peers

Mitsuhiko Osaki
Comparison fields: 5 of 128
  • Molecular Biology 4.1k
  • Cancer Research 1.8k
  • Oncology 1.3k
  • Surgery 955
  • Pulmonary and Respiratory Medicine 727
Replace Lixin Wei with:
Lixin Wei China
Kyu Yun Jang South Korea
Georg Feldmann Germany
Yiwei Chu China
Maxwell Sehested Denmark
Latifa Bakiri Austria
Takeshi Uchiumi Japan
Marian H. Harris United States
Hongchuan Jin China
Xiao‐Feng Zhu China
Mitsuhiko Osaki relative to Lixin Wei China Lixin Wei's profile →
Citations per field
00.5×1.5×
Lixin Wei · 1×
Citations per year

Countries citing papers authored by Mitsuhiko Osaki

Since Specialization
Citations

This map shows the geographic impact of Mitsuhiko Osaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuhiko Osaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuhiko Osaki more than expected).

Fields of papers citing papers by Mitsuhiko Osaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuhiko Osaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuhiko Osaki. The network helps show where Mitsuhiko Osaki may publish in the future.

Co-authorship network of co-authors of Mitsuhiko Osaki

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuhiko Osaki. A scholar is included among the top collaborators of Mitsuhiko Osaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuhiko Osaki. Mitsuhiko Osaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 6
6 5
7 13
8 22
9 43
10 19
11 5
12 1
13 84
14 25
15 25
16 167
17 23
18
A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
16
19 19
20
Expression of growth factors and their receptors in human early colorectal carcinomas: immunohistochemical study.
34

About Mitsuhiko Osaki

Mitsuhiko Osaki is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 158 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (18 papers), RNA Interference and Gene Delivery (16 papers) and MicroRNA in disease regulation (12 papers). The work is most often cited by research in Cancer Research (1.8k citations), Geriatrics and Gerontology (409 citations) and Molecular Biology (4.1k citations). Mitsuhiko Osaki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hisao Ito, M Oshimura, Futoshi Okada, Mitsuo Oshimura, Takahiro Ochiya, Fumitaka Takeshita, Toshiaki Inoue, Yusuke Yamamoto, Masaharu Hiratsuka and Nobuaki Kaibara. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026